VZV gE Antibodies

Santa Cruz Biotechnology features a diverse variety of VZV gE monoclonal antibodies for studying glycoprotein E (gE) of Varicella-Zoster Virus (VZV). VZV gE monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). VZV gE plays a crucial role in viral spread and establishment of latency in the host, making it a significant target for understanding VZV pathogenesis and developing therapeutic strategies. By investigating VZV gE, researchers can uncover important aspects of immune response to VZV and the mechanisms underlying herpesvirus infections. Understanding VZV gE function contributes to knowledge about viral entry mechanisms and cell-to-cell spread. Research on VZV gE advances our understanding of virus-host interactions and potential therapeutic interventions. Investigating VZV gE helps reveal how the virus establishes and maintains latency in neural tissues. VZV gE research provides insights into viral glycoprotein trafficking and processing in infected cells. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of VZV pathogenesis and potential therapeutic approaches.